𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Docetaxel and cisplatin combination chemotherapy in anthracyclines-resistant advanced breast cancer

✍ Scribed by Hailin Xiong; Zhujun Liu; Xin Cheng; Kai Li

Publisher
Springer
Year
2007
Tongue
English
Weight
334 KB
Volume
6
Category
Article
ISSN
1610-1979

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Cisplatin plus VP-16 combination chemoth
Cisplatin plus VP-16 combination chemotherapy in advanced refractory breast cancer
✍ Dr. Fikri IΓ§li; Nazan GΓΌunel; Dilek DinΓ§lol; Handan KaraoΗ§uz; Ahmet Demirkazik πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 224 KB

Twenty-nine patients with advanced refractory breast cancer were treated with cisplatin 20 mg/m2/d and VP-16 100 mg/d for 5 days every 3 4 weeks. Ten patients received mitomycin C 10 mg/m2 every 6 weeks additionally. Partial response was obtained in 10 of 26 evaluable patients (38%). The response ra